Dow Dips as Fed Fears Slam Tech Stocks – Hot Economic Data Rattles Wall Street (Sept 25, 2025)

Comcast (CMCSA) Stock Today — Nov. 7, 2025: Sky–ITV Talks and a Potential WBD Bid Put M&A in Focus as Shares Hover Near $27

Published: November 7, 2025

Key takeaways

  • CMCSA trades around $27 this afternoon after a choppy session, as investors weigh fresh deal headlines. As of 19:33 UTC (2:33 p.m. ET), shares changed hands at $27.28, within a $27.02–$27.77 intraday range on ~20.9M shares.
  • Sky, owned by Comcast, entered preliminary talks to buy ITV’s U.K. TV unit (including the ITVX streamer) in a deal valued at about £1.6B (~$2.1B)—a move that could boost Comcast’s U.K. footprint but likely faces regulator scrutiny. [1]
  • Reuters reports Comcast has hired bankers and gained data-room access to explore a bid for Warner Bros. Discovery’s studio and streaming assets, keeping consolidation chatter front and center. [2]
  • Recent context: CMCSA closed $27.31 yesterday (Nov. 6) and has lagged peers this year; Barron’s notes shares are down roughly 27% YTD as cord-cutting pressures persist. [3]

Comcast stock price snapshot (Nov. 7, 2025)

Comcast Corporation (NASDAQ: CMCSA) traded modestly lower today, holding near the $27 handle. As of 19:33 UTC (2:33 p.m. ET), the stock printed $27.28 after opening at $27.56, with volume around 20.9 million shares. Intraday, CMCSA ranged $27.02–$27.77, reflecting an active tape as investors reacted to fresh M&A headlines.

For reference, CMCSA finished Thursday at $27.31, setting the baseline for today’s moves. [4]


What’s moving CMCSA today: two deal headlines

1) Sky–ITV talks in the U.K.

ITV confirmed it is in preliminary discussions to sell its free‑to‑air TV business and ITVX streaming platform to Sky, Comcast’s U.K. pay‑TV arm, for about £1.6 billion (~$2.15 billion). Analysts immediately flagged potential competition and media ownership questions, given the combined weight in U.K. TV advertising and Sky’s existing footprint. Any agreement would exclude ITV Studios, which has been the subject of separate industry interest. The news sent ITV shares sharply higher this morning and put a fresh spotlight on Comcast’s international strategy post‑Sky. [5]

2) Comcast weighs a Warner Bros. Discovery bid

Separately, Reuters reports that Comcast has retained Goldman Sachs and Morgan Stanley and obtained data‑room access to evaluate a possible bid for Warner Bros. Discovery’s studio and streaming businesses—a sign of serious diligence even though no offer is guaranteed. The report also notes other potential suitors circling portions of WBD, underscoring an escalating M&A cycle across media. [6]


Why this matters for the stock

The U.K. deal could deepen Comcast’s linear + streaming reach in Europe through Sky while accelerating ITV’s pivot toward content production. But it also poses regulatory risk and integration questions that investors will price in. Meanwhile, a WBD move would be transformational—and complex—given U.S. antitrust dynamics and the strategic overlap with NBCUniversal/Peacock. Both headlines keep optionalities open but also add execution risk, helping explain CMCSA’s subdued intraday reaction despite elevated news flow. [7]


The broader setup investors are watching

  • Year-to-date performance: CMCSA has underperformed in 2025, with Barron’s citing roughly –27% YTD amid broadband pressure and a tougher linear TV backdrop. Today’s tape reflects that cautious posture even as deal speculation swirls. [8]
  • M&A lens: MarketWatch framed Comcast’s stance as more aggressive in the current wave of media consolidation (ITV talks + WBD exploration), positioning the company to reshape its portfolio as consumer viewing and advertising continue shifting to digital. [9]

Near‑term catalysts

  • Versant spin‑off investor day (Dec. 4, 2025): Comcast’s planned spin‑off of most U.S. cable networks—Versant (planned ticker: VSNT)—will host its inaugural Investor Day on Dec. 4 in New York, outlining strategy and financial priorities. Comcast and Versant expect the spin to complete in early 2026, subject to customary conditions. For CMCSA holders, the event could clarify capital allocation and the post‑spin asset mix. [10]
  • Dividend track: Comcast most recently declared a $0.33 quarterly dividend (Oct. 30) with the next payment slated for Feb. 4, 2026 to holders of record Jan. 14, 2026—useful context for income‑oriented investors eyeing total return while the stock consolidates. [11]

Other headlines touching Comcast today (lower impact)

  • Institutional flows: Achmea Investment Management boosted its CMCSA stake in Q2, according to a fresh 13F‑based summary—incremental, but supportive of steady institutional ownership. [12]
  • Local footprint: Comcast announced the opening of a new Xfinity store in San Bruno, CA—minor to the stock but part of ongoing retail/channel updates. [13]

Bottom line

Today’s CMCSA trade is about optionality vs. execution. Sky’s talks for ITV’s TV unit and a reported look at WBD’s studio/streaming assets underline Comcast’s willingness to lean into scale where it sees strategic fit. Those moves could reshape the portfolio—but they also come with regulatory and integration hurdles. With shares hovering near $27, investors appear to be waiting for more concrete deal terms and clarity from the Versant Investor Day before re‑rating the stock. [14]


Disclosure: This article is for informational purposes only and does not constitute investment advice. Always do your own research.

AT&T 5Gbps Fiber Internet at Home

References

1. www.reuters.com, 2. www.reuters.com, 3. www.marketwatch.com, 4. www.marketwatch.com, 5. www.reuters.com, 6. www.reuters.com, 7. www.reuters.com, 8. www.barrons.com, 9. www.marketwatch.com, 10. www.businesswire.com, 11. seekingalpha.com, 12. www.marketbeat.com, 13. www.benzinga.com, 14. www.reuters.com

Stock Market Today

  • INTC: Intel Eyes AI Chip Partnership With Tesla as Shares Rise on Premarket Buzz
    November 8, 2025, 1:00 AM EST. Intel shares rose more than 2% in premarket trading after reports of a potential AI chip partnership with Tesla to expand manufacturing capacity. While no formal agreement has been announced, early discussions have buoyed investor sentiment as automakers seek AI hardware capacity. A deal could help Intel boost its foundry services and compete with Nvidia and AMD in the fast-growing AI-chip market, fitting its broader turnaround plan to widen manufacturing leadership through external partnerships. GuruFocus notes one-year targets from 36 analysts averaging $35.04 (high $50, low $18), implying a downside of about 6% from the current price of $37.24. GuruFocus' GF Value estimates Intel at $23.64 in one year, signaling a larger downside (~36%).
  • UnitedHealth Group (UNH) Valuation Check After Recent Price Weakness: Undervalued or Risks Ahead?
    November 8, 2025, 12:58 AM EST. UnitedHealth Group (UNH) has fallen roughly 12% over the last month, with volatility and a weak year-to-date showing longer-term underperformance vs the market. This raises questions about growth prospects and whether the pullback marks a long-run undervaluation or a change in sentiment. Shares sit below recent highs and some analyst targets, fueling debate about intrinsic value. On the bull side, consensus fair value literature points to meaningful upside (e.g., well above current close) supported by strong free cash flow and regulatory visibility that could sustain expansion. On the flip side, risks like Medicare Advantage margin pressure and potential missteps with new risk models could derail the recovery. Investors may weigh a potential buying opportunity against these headwinds before changing their watchlists.
  • Spot Solana ETFs Draw Strong Inflows as SOL Slips; BSOL Tops Week
    November 8, 2025, 12:38 AM EST. US spot Solana ETFs drew solid demand in their first week, even as SOL slid about 20% from a $205 high to around $165. The price weakness came as BTC and ETH fell roughly 6% and 12%. CoinShares data show weekly inflows of about $421 million, making BSOL the top crypto ETF of the week. Bitwise's BSOL attracted roughly $199 million in fresh funds, starting with nearly $223 million seed; GSOL pulled in $2.2 million and carries $102 million AUM after converting from a closed-end product. Fees run 0.20% for BSOL and 0.35% for GSOL (vs 1.5% on GBTC/ETHE). K33's Vetle Lunde called the launch a "very solid" start amid broader crypto fund outflows.
  • Kennedy-Wilson (KW) Valuation Revisited After 24% Rally: Is the Stock Undervalued?
    November 8, 2025, 12:36 AM EST. Kennedy-Wilson Holdings (KW) surged over 24% this week, renewing investor focus on its real estate management story. Despite a negative one-year TSR, near-term momentum suggests renewed optimism, while longer-term performance remains a question mark. The stock trades near analyst targets, with revenue gains yet ongoing net income challenges. Our narrative-based fair value is $11.00, implying the shares may be undervalued versus the story, but a DCF view puts fair value at about $1.31, signaling potential valuation gaps. The current price at $9.40 sits above the DCF value but below the narrative target, underscoring contrasts between capital deployment strength, recurring fees, and margin expansion against macro risks like rental demand shifts and tighter credit. Consider the risk-reward carefully.
  • Merus (MRUS) Valuation Under Scrutiny After Recent Share Rally
    November 8, 2025, 12:34 AM EST. Merus (MRUS) has surged, with a 90-day return of 48.8%, and a year-to-date gain of 125.1%, fueling optimism about growth prospects. The stock's momentum is backed by a 74.7% 1-year TSR and a 624.7% five-year TSR, but valuation remains contentious. Merus trades at a price-to-book (P/B) of 9.3x, well above the US biotech industry average of 2.4x, though it sits closer to peers at 13.3x. The raised multiple implies aggressive growth expectations or breakthrough potential, yet the company remains unprofitable. If fundamentals temper expectations or clinical data disappoints, multiple re-rating could hit the stock. With shares near analyst targets, risk-reward hinges on future profitability and trial outcomes rather than past momentum.
Petrobras (PBR) jumps on Q3 results, R$12.16bn dividend and faster capex — Today, 7 November 2025
Previous Story

Petrobras (PBR) jumps on Q3 results, R$12.16bn dividend and faster capex — Today, 7 November 2025

ServiceNow (NOW) Surges on Blowout Q3 Earnings and 5-for-1 Stock Split Amid AI Boom
Next Story

ServiceNow Today (Nov 7, 2025): 5‑for‑1 Stock Split Update, New Figma Integration, Wind River Private‑Cloud Option, and NTT DATA Partnership

Go toTop